Natural killer T (NKT) cells are a unique T-cell subset defined by the co-expression of NK-cell markers and a T-cell receptor (TCR), and are characterized by their ability to rapidly produce ...

A new study published in Mucosal Immunology shows that α-galactosylceramide (α-GalCer) serves as a potent adjuvant by activating natural killer T (NKT) cells, which promote effective cross ...

BrightPath CEO Ken Nagai said: “The use of NKT cells as effectors in allogeneic CAR-T therapy represents a promising strategy, offering not only direct cytotoxicity but also indirect anti-tumour ...

GRI Bio, Inc., a biotechnology company focused on developing Natural Killer T (NKT) cell modulators for inflammatory, fibrotic, and autoimmune diseases, announced that the European Patent Office ...